Laboratorio Echevarne
Laboratorio Echevarne is recorded as a service provider in 7 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 7 of 7 trials · Latest update first
A multicenter, randomized, double-blind, placebo-controlled clinical trial to evaluate the efficacy and safety of two concentrations of a mixture of depigmented polymerized allergenic extracts of D. pteronyssinus and D. farinae in patients with allergic rhinoconjunctivitis with or without controlled asthma
Sponsor LETI Pharma S.L.U.
- Start (EU)
- Latest update
- Estimated end
- Not reported
A double blind, randomized, placebo-controlled, adaptive 24-week Phase II trial to evaluate the efficacy of vafidemstat in negative symptoms and cognitive impairment associated with schizophrenia (EVOLUTION Study)
Sponsor Oryzon Genomics S.A.
- Start (EU)
- Latest update
- Estimated end
- Not reported
Multicenter, randomized, open-label with blind evaluation, non-inferiority clinical trial, with parallel groups to evaluate the efficacy and safety of the topical application of Impetine® Gel (mupirocin 20 mg/g, Gel) compared with Bactroban® (mupirocin 20 mg/g, Ointment) for the treatment of impetigo in paediatric population
Sponsor Laboratorios Ojer Pharma S.L.
- Start (EU)
- Latest update
- Estimated end
- Not reported
A multicentre, single arm trial on contraceptive efficacy, safety and tolerability of LVDS (Levonorgestrel Vaginal Delivery System) during 13 cycles.
Sponsor Chemo Research S.L.
- Start (EU)
- Latest update
- Estimated end
- Not reported
A pivotal, multicentre, randomised, open-label, parallel-group trial on contraceptive efficacy, safety and tolerability of LVDS (Levonorgestrel Vaginal Delivery System) during 9 cycles in comparison with Desogestrel tablets 0.075 mg.
Sponsor Chemo Research S.L.
- Start (EU)
- Latest update
- Estimated end
- Not reported
A double-blind, randomised, dose-finding trial to assess the efficacy, safety and pharmacokinetics of a single dose of albaconazole versus fluconazole and placebo in the treatment of acute Candida vulvovaginitis
Sponsor Palau Pharma S.L.
- Start (EU)
- Latest update
- Estimated end
- Not reported
Phase I-II Study to Assess the Safety, Tolerability and Efficacy of Lurbinectedin and Dostarlimab in Advanced/Recurrent Endometrial Cancer Patients with Disease Progression after Prior Therapy with Platinum-based Chemotherapy. LiDer trial
Sponsor Vall D Hebron Institute Of Oncology
- Start (EU)
- Not reported
- Latest update
- Estimated end
- Not reported
Questions about this trial experience
What services are recorded for Laboratorio Echevarne?
The 2026-10-09 snapshot links Laboratorio Echevarne to 7 distinct CTIS trials. Recorded services include Laboratory services, Microbiological testing. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Laboratorio Echevarne?
The most frequently recorded therapeutic areas are Allergy, Psychiatry, Respiratory. Recorded phases include Phase 2, Phase 3. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Laboratorio Echevarne conducted?
The linked trials record locations in 10 countries, including Spain, Poland, Romania, Slovakia, Czechia. These are trial locations, not confirmed office locations or countries where Laboratorio Echevarne delivered services.
What can this page tell me about Laboratorio Echevarne's trial experience?
Browse 7 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Laboratorio Echevarne. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Laboratorio Echevarne S.A.